poisar

Stocks · News reference

Fractyl Health Announces One-Year Results From Its REMAIN-1 Midpoint Cohort; Results Reinforce Potential Of Revita DMR System To Become First Durable Therapy For Post-GLP-1 Weight Maintenance

Jul 15, 2026, 10:02 AMBenzinga Newsdesk

Key Findings:Dose-dependent durability confirmed at one year: In the full modified intention-to-treat (mITT) population (N=45), a single Revita procedure reduced weight regain by approximately 40% versus sham at one

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

GUTS
Source
benzinga
Observed
Jul 15, 2026, 10:02 AM
Checked
Jul 15, 2026, 10:02 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading